Vitreomakuläres Traktionssyndrom (VMTS)

M. M. Maier; N. Feucht; S. Burzer; C. P. Lohmann

doi:10.1055/s-0032-1328641

Vitreomakuläres Traktionssyndrom (VMTS)

Translated title of the contribution: Vitreomacular traction syndrome (VMTS)

M. M. Maier, N. Feucht, S. Burzer, C. P. Lohmann

Department of Ophthalmology

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

In vitreomacular traction syndrome (VMTS) an anomalous posterior vitreous detachment (APVD) with persistant symptomatic vitreoretinal adhesion is seen. The adhesion leads to a thickened macula, to macular oedema and a reduction of BCVA. Modern imaging techniques like spectral domain OCT (SD-OCT) allow a detailed imaging of the retinal microstructure and the vitreoretinal interface. Vitreomacular adhesions and their effect on the retina can be visualised. Until now, the treatment option for VMTS was and is vitreoretinal surgery. In studies pharmacological vitreolysis has shown a therapeutic effect in patients with symptomatic adhesion and traction. The results of these studies represent an important step towards a pharmacological treatment of VMTS.

Translated title of the contribution	Vitreomacular traction syndrome (VMTS)
Original language	German
Pages (from-to)	920-928
Number of pages	9
Journal	Klinische Monatsblatter fur Augenheilkunde
Volume	230
Issue number	9
DOIs	https://doi.org/10.1055/s-0032-1328641
State	Published - 2013

Access to Document

10.1055/s-0032-1328641

Cite this

@article{df64cb21cbf4402b8730f1fc3394f0b7,

title = "Vitreomakul{\"a}res Traktionssyndrom (VMTS)",

abstract = "In vitreomacular traction syndrome (VMTS) an anomalous posterior vitreous detachment (APVD) with persistant symptomatic vitreoretinal adhesion is seen. The adhesion leads to a thickened macula, to macular oedema and a reduction of BCVA. Modern imaging techniques like spectral domain OCT (SD-OCT) allow a detailed imaging of the retinal microstructure and the vitreoretinal interface. Vitreomacular adhesions and their effect on the retina can be visualised. Until now, the treatment option for VMTS was and is vitreoretinal surgery. In studies pharmacological vitreolysis has shown a therapeutic effect in patients with symptomatic adhesion and traction. The results of these studies represent an important step towards a pharmacological treatment of VMTS.",

keywords = "anomalous posterior vitreous detachment (APVD), ocriplasmin, pharmacological vitreolysis, vitreomacular traction syndrome",

author = "Maier, {M. M.} and N. Feucht and S. Burzer and Lohmann, {C. P.}",

year = "2013",

doi = "10.1055/s-0032-1328641",

language = "Deutsch",

volume = "230",

pages = "920--928",

journal = "Klinische Monatsblatter fur Augenheilkunde",

issn = "0023-2165",

publisher = "Ferdinand Enke Verlag",

number = "9",

}

TY - JOUR

T1 - Vitreomakuläres Traktionssyndrom (VMTS)

AU - Maier, M. M.

AU - Feucht, N.

AU - Burzer, S.

AU - Lohmann, C. P.

PY - 2013

Y1 - 2013

N2 - In vitreomacular traction syndrome (VMTS) an anomalous posterior vitreous detachment (APVD) with persistant symptomatic vitreoretinal adhesion is seen. The adhesion leads to a thickened macula, to macular oedema and a reduction of BCVA. Modern imaging techniques like spectral domain OCT (SD-OCT) allow a detailed imaging of the retinal microstructure and the vitreoretinal interface. Vitreomacular adhesions and their effect on the retina can be visualised. Until now, the treatment option for VMTS was and is vitreoretinal surgery. In studies pharmacological vitreolysis has shown a therapeutic effect in patients with symptomatic adhesion and traction. The results of these studies represent an important step towards a pharmacological treatment of VMTS.

AB - In vitreomacular traction syndrome (VMTS) an anomalous posterior vitreous detachment (APVD) with persistant symptomatic vitreoretinal adhesion is seen. The adhesion leads to a thickened macula, to macular oedema and a reduction of BCVA. Modern imaging techniques like spectral domain OCT (SD-OCT) allow a detailed imaging of the retinal microstructure and the vitreoretinal interface. Vitreomacular adhesions and their effect on the retina can be visualised. Until now, the treatment option for VMTS was and is vitreoretinal surgery. In studies pharmacological vitreolysis has shown a therapeutic effect in patients with symptomatic adhesion and traction. The results of these studies represent an important step towards a pharmacological treatment of VMTS.

KW - anomalous posterior vitreous detachment (APVD)

KW - ocriplasmin

KW - pharmacological vitreolysis

KW - vitreomacular traction syndrome

UR - http://www.scopus.com/inward/record.url?scp=84883463537&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1328641

DO - 10.1055/s-0032-1328641

M3 - Artikel

C2 - 23842874

AN - SCOPUS:84883463537

SN - 0023-2165

VL - 230

SP - 920

EP - 928

JO - Klinische Monatsblatter fur Augenheilkunde

JF - Klinische Monatsblatter fur Augenheilkunde

IS - 9

ER -

Vitreomakuläres Traktionssyndrom (VMTS)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this